Pubertal development in children after BMT.

被引：0
|
作者：
Cohen, A
Rovelli, A
van Lint, MT
Dassori, A
Arrigo, C
Terenzani, L
Gaiero, A
Uderzo, C
Bacigalupo, A
机构：
[1] Gaslini Inst, Dept Pediat, Genoa, Italy
[2] S Gerardo Hosp, Pediat BMT Unit, Monza, Italy
[3] S Martino Hosp, BMT Ctr, Genoa, Italy
来源：
BONE MARROW TRANSPLANTATION | 1999年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
413
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [1] The possibility of becoming a parent after BMT.
    Keskimäki, R
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S261 - S261
  • [2] Oral disturbances after pediatric BMT.
    Anak, S
    Agirbas, E
    Yalman, N
    Agirbasli, H
    Tanyeri, H
    Güc, Ö
    Özgenc, S
    Bilgen, H
    Can, E
    Gedikoglu, G
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 : S160 - S160
  • [3] Pancytopenia associated to CMV infection after allogeneic BMT.
    Stemmelin, GR
    Shanley, C
    Ceresetto, J
    Rabinovich, O
    Mendizabal, G
    Contino, A
    Labra, L
    Schamun, A
    Tamashiro, M
    Gutierrez, M
    Bullorsky, EO
    [J]. BLOOD, 2000, 96 (11) : 344B - 344B
  • [4] Long term effects of IVIG treatment on IgM repertoire development after allogeneic BMT.
    Bjork, IN
    Fesel, C
    Malanchere, E
    Coutinho, A
    Lundkvist, I
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 : S133 - S133
  • [5] Transient leukocyte slump: A common occurrence after allogeneic BMT.
    Seber, A
    Zahurak, ML
    Noga, SJ
    Jones, RJ
    Goodman, SN
    Vogelsang, GB
    [J]. BLOOD, 1995, 86 (10) : 395 - 395
  • [6] Decreased gelsolin levels are associated with interstitial pneumonia after allogeneic BMT.
    DiNubile, MJ
    Antin, JH
    Bressler, S
    Stossel, T
    Ferrara, JLM
    [J]. BLOOD, 1998, 92 (10) : 683A - 683A
  • [7] Chronic GvHD with pulmonary involvement after filgrastim primed allogeneic BMT.
    Grosskreutz, CL
    Rodriguez, A
    Scigliano, E
    Ross-Dodds, V
    Egan, R
    Fruchtman, SM
    Isola, LM
    [J]. BLOOD, 2002, 100 (11) : 450B - 450B
  • [8] Allogeneic peripheral blood progenitor cells for treatment of relapse after BMT.
    Majolino, I
    Glass, B
    Dreger, P
    Scime, R
    Santoro, A
    Vasta, S
    Suttorp, M
    Haferlach, T
    Schmitz, N
    [J]. EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 640 - 640
  • [9] Physical, social and emotional well-being after allogeneic BMT.
    Heinonen, H
    Volin, L
    Uutela, A
    Barrick, C
    Zevon, Z
    Ruutu, T
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 : S159 - S159
  • [10] Improved outcome for unrelated donor (UD) BMT in children now compares with matched family donor (MFD) BMT.
    Veys, PA
    Meral, A
    Goulden, A
    Hassan, A
    Armstrong, J
    Bennett-Rees, N
    Webb, D
    Gerritsen, B
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 66 - 66
12345